Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Inc. (NASDAQ: TLRY) has been one of the better pot stocks, but that is not saying much.

Does Tilray Stock Have Enough Cash to Outlast the Market?

Jefferies now believes the struggling Canadian marijuana company is a sell.

Tilray's Stock Falls 6% on Analyst Downgrade

Aurora Cannabis

Aphria

Canopy Growth

Cronos Group

HEXO Corp

OrganiGram Holdings Inc.

Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability.

Cannabis Stocks’ Short Interest Up in Smoke

Cannabis companies are getting hard hit by the coronavirus. These three companies are getting the worst of it.

3 Pot Stocks to Avoid as the Coronavirus Pandemic Continues

Chesapeake Energy

Qurate Retail Inc

Qurate Retail Inc - Ordinary Shares - Series B

Range Resources

Southwestern Energy

All of a sudden, renewed optimism about the government stimulus package and a handful of data points suggesting the spread of COVID-19 may be slowing has the S&P 500 up 10.3% since April 1.

8 Stocks To Sell Into The Market Rally

Tilray (TLRY) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

Tilray (TLRY) in Focus: Stock Moves 9.6% Higher

It makes many pot stocks high-risk investments to hold on to amid the coronavirus pandemic.

1 Major Problem for the Cannabis Industry

The shares could theoretically be sold on the market starting this Friday.

Tilray Releases 11 Million Shares From Lock-Up

Canada-based Tilray Inc. (NASDAQ: TLRY) on Tuesday announced that the company’s board had approved the release of 11 million shares of Class 2 common stock held by former equity holders of Privateer Holdings.

Tilray Stock Dives as Shares Released From Lockup Period

Canadian cannabis company Tilray Inc. TLRY, -27.36% said Tuesday its board has agreed to release 11 million shares of class 2 common stock held by the former equity holders of Privateer Holdings Inc.

Tilray board agrees to release 11 million class 2 shares to be released from lock-up agreements

Innovative Industrial Properties

MedMen Enterprises Inc.

Cannabis stocks have breathed new life, but most are worth avoiding.

These 5 Pot Stocks Are Up Over 100% in a Week, but Only 1 Is Worth Buying

A month ago, Canada-based cannabis company Tilray Inc. (NASDAQ: TLRY) closed at $16.57 a share.

Why Tilray Stock Is Soaring Again After a Terrible Year

Boeing

There are some great deals out there today.

2 Stocks That Could  Double Your Money

Tilray Inc (NASDAQ: TLRY) shares are trading sharply higher potentially on a rebound following weakness in the sector.

Why Tilray's Stock Is Trading Higher Today

Amplify Alternative Harvest ETF

Even on a good day for the market, cannabis stocks didn't show much optimism.

Have Marijuana Investors Just Given Up?

Canopy Growth and HEXO, to name two, are contributing to the battle.

Canadian Pot Companies Donate Masks, Materials to Coronavirus Fight

More than 70 companies and organizations involved in the nascent industry have sent an official letter to Canadian officials.

Canadian Cannabis Companies Ask to Be Included in Ottawa's Coronavirus Aid Package

British Columbia marijuana users will still have to pick up and pay for their goods in-store, however.

Fighting Coronavirus, a Key Canadian Province Now Allows Pot Dispensaries to Accept Online Recreational Orders

Hemp stocks have suffered significant losses over the past year.

Is the Hemp Hype Over?

TLRY stock crashed following the company's $90 million stock offering last week. The selloff is understandable given the offering was conducted at the worst possible time for the company.

Tilray Is Flirting with Disaster

BofA Securities turned bearish on one cannabis stock, bullish on another and moved to a neutral stance on a third Thursday.

BofA On Organigram, Tilray, Aphria's Cash, Demand Trends

The cannabis stock has lost significant market value due to a sequential decline in quarterly sales, mounting losses, and the broader market sell-off.

Down 90% in the Past Year, Is Tilray Stock a Buy?

Customers are taking fewer trips to dispensaries as COVID-19 continues to spread.

Cannabis Stores Prepare for Coronavirus as Buyers Stock Up on Pot While They Can

Tilray's hemp business was a bright spot in the company's otherwise disappointing quarterly update.

Can Tilray Conquer the U.S. Hemp Industry?

Anheuser-Busch InBev

Coca-Cola

Constellation Brands

The industry could face another challenging year in 2020 if edibles, and drinkables, don't perform well.

News for Tilray Brands Stock (TLRY)